Agilent Sponsors the Nonprofit “My Green Lab”
Agilent Technologies, Inc. has become a sponsor of My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific research.
Agilent Technologies, Inc. (Santa Clara, California) has become a sponsor of My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific research.
Agilent chose to support My Green Lab because of its “holistic approach to sustainability and their understanding of the interconnectivity between all the parts that make up a laboratory-from chemicals to instruments to the environment,” according to the company.
“Sustainability is a key consideration in all our activities, and we look forward to ultimately passing on the benefits of our efforts and innovation to make better informed, sustainable choices”, said Mike McMullen, Agilent CEO.
Agilent is currently working with My Green Lab to have the company’s instruments independently audited for the organization’s Accountability, Consistency, and Transparency (ACT) label. The ACT label provides information about the environmental impact of manufacturing, using, and disposing of a product and its packaging.
“We are really excited to be working with Agilent,” My Green Lab CEO Allison Paradise said in a statement. “The fact that Agilent is willing to highlight sustainability through our ACT labelling program speaks to Agilent’s leadership in this area.”
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
